These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36335571)

  • 1. Increased severe primary graft dysfunction in left ventricular assist device patients following united network for organ sharing allocation changes.
    Guo A; Kotkar K; Jocher B; Botkin KW; Britt D; Fischer I; Masood MF; Schilling J; Itoh A
    Clin Transplant; 2023 Jan; 37(1):e14833. PubMed ID: 36335571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right Heart Failure While on Left Ventricular Assist Device Support Is Associated with Primary Graft Dysfunction.
    King PM; Raymer DS; Shuster J; Crain M; Bhatia A; Hartupee J; Schilling JD
    ASAIO J; 2020; 66(10):1137-1141. PubMed ID: 33136601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of heart transplant recipients bridged with percutaneous versus durable left ventricular assist devices.
    Xia Y; Kim JS; Eng IK; Nsair A; Ardehali A; Shemin RJ; Kwon MH
    Clin Transplant; 2023 Apr; 37(4):e14904. PubMed ID: 36594638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of left ventricular assist device recipients transplanted before and after the new donor heart allocation system.
    Doulamis IP; Inampudi C; Kourek C; Mandarada T; Kuno T; Asleh R; Briasoulis A
    Artif Organs; 2022 Dec; 46(12):2460-2468. PubMed ID: 35841284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device bridging to heart transplantation: Comparison of temporary versus durable support.
    Hess NR; Hickey GW; Keebler ME; Huston JH; McNamara DM; Mathier MA; Wang Y; Kaczorowski DJ
    J Heart Lung Transplant; 2023 Jan; 42(1):76-86. PubMed ID: 36182653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation.
    Uriel N; Jorde UP; Woo Pak S; Jiang J; Clerkin K; Takayama H; Naka Y; Schulze PC; Mancini DM
    J Heart Lung Transplant; 2013 Feb; 32(2):188-95. PubMed ID: 23352392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging to transplant with HeartMate 3 left ventricular assist devices in the new heart organ allocation system: An individualized approach.
    Uriel MH; Clerkin KJ; Takeda K; Naka Y; Sayer GT; Uriel N; Topkara VK
    J Heart Lung Transplant; 2023 Jan; 42(1):124-133. PubMed ID: 36272893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Left-Ventricular Assist Device-Related Complications on Posttransplant Graft Survival.
    Chauhan D; Okoh AK; Fugar S; Karanam R; Baran D; Zucker M; Camacho M; Russo MJ
    Ann Thorac Surg; 2017 Dec; 104(6):1947-1952. PubMed ID: 28935351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients: a single-center experience in Japan.
    Seguchi O; Fujita T; Murata Y; Sunami H; Sato T; Watanabe T; Nakajima S; Kuroda K; Hisamatsu E; Sato T; Yanase M; Hata H; Wada K; Ishibashi-Ueda H; Kobayashi J; Nakatani T
    Heart Vessels; 2016 Apr; 31(4):555-62. PubMed ID: 25682298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD; Piacentino V; Cuevas AD; Depp T; Daneshmand MA; Hernandez AF; Felker GM; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.